Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation

Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Eisenga, Michele F., De Jong, Maarten A., Leaf, David E., Nolte, Ilja M., De Borst, Martin H., Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356141/
https://ncbi.nlm.nih.gov/pubmed/32512806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061737
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi